KHN

A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.

President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Epidemiologists and disease modelers tried to predict what would happen when students moved back to campus. Although some universities listened to their advice, that didn’t stop outbreaks from happening.

The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.

In the most comprehensive tally of such injuries to date, the Physicians for Human Rights scoured publicly available data — including social media, news accounts and lawsuits — to document and name victims of summer protests. Still, the group cautions, it’s likely an undercount.

Studies show that at least half of ground ambulance rides across the nation leave patients with “surprise” medical bills. And a $300-a-mile ride is not unusual. Yet federal legislation to stem what’s known as balance billing has largely ignored ambulance costs.

Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.

Inspections for lead hazards and blood testing for lead have dropped significantly just as kids are spending more time in the places where their exposure to the poisonous metal is highest: their homes.

“The Quarantine 15” — weight gain due to inactivity during the pandemic — is a real phenomenon. Here are some ways to fight it.

Florida Gov. Ron DeSantis says airplanes are not vectors for the spread of COVID-19 and that flying is “something that is safe for people to do.” Is the evidence really so clear?

About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.

When people had a health insurance headache, these two words were a relief: “Call Barbara.” No problem was too big, or too small, she’d fix it.

Check out KHN’s video series — Behind the Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.

Once there were 23 of these nonprofit plans across 26 states; in January there will be only three, serving Maine, Wisconsin, Montana, Idaho and Wyoming.

Voters in Montana, Nebraska, South Dakota and several other conservative-leaning states will decide in November whether to legalize medical or recreational marijuana.